Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Gerstein

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Annals of Internal Medicine|April 17, 2001
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trialJ F Mann, H C Gerstein, J Pogue, et al.
Advances in Nephrology From the Necker Hospital|November 24, 1999
Antihypertensive therapy in patients with type 2 diabetes mellitus: focus on nephropathyJ F Mann, U Thomae, H C Gerstein, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004
Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trialH C Gerstein, J Garon, C Joyce, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesM J McQueen, E Lonn, H C Gerstein, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1987
Separate induction of MHC and thyroid microsomal antigen (McAg) expression on thyroid cell monolayers: enhancement of lectin-induced McAg expression by interferon-gammaY Iwatani, M Iitaka, H C Gerstein, et al.
Diabetes Care|July 1, 1995
Feasibility and acceptability of a proposed infant feeding intervention trial for the prevention of type I diabetesH C Gerstein, J R Simpson, S Atkinson, et al.
Diabetes Care|November 1, 1996
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention EvaluationH C Gerstein, J Bosch, J Pogue, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 1, 1987
The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidismH C Gerstein, B Rastogi, Y Iwatani, et al.
Journal of Endocrinological Investigation|December 1, 1986
Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity testM Iitaka, J Bernstein, H C Gerstein, et al.
Canadian Medical Association Journal|July 1, 1984
AIDS in a patient with hemophilia receiving mainly cryoprecipitateH C Gerstein, M M Fanning, S E Read, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Annals of Internal Medicine|April 17, 2001
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trialJ F Mann, H C Gerstein, J Pogue, et al.
Advances in Nephrology From the Necker Hospital|November 24, 1999
Antihypertensive therapy in patients with type 2 diabetes mellitus: focus on nephropathyJ F Mann, U Thomae, H C Gerstein, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004
Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trialH C Gerstein, J Garon, C Joyce, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesM J McQueen, E Lonn, H C Gerstein, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1987
Separate induction of MHC and thyroid microsomal antigen (McAg) expression on thyroid cell monolayers: enhancement of lectin-induced McAg expression by interferon-gammaY Iwatani, M Iitaka, H C Gerstein, et al.
Diabetes Care|July 1, 1995
Feasibility and acceptability of a proposed infant feeding intervention trial for the prevention of type I diabetesH C Gerstein, J R Simpson, S Atkinson, et al.
Diabetes Care|November 1, 1996
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention EvaluationH C Gerstein, J Bosch, J Pogue, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 1, 1987
The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidismH C Gerstein, B Rastogi, Y Iwatani, et al.
Journal of Endocrinological Investigation|December 1, 1986
Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity testM Iitaka, J Bernstein, H C Gerstein, et al.
Canadian Medical Association Journal|July 1, 1984
AIDS in a patient with hemophilia receiving mainly cryoprecipitateH C Gerstein, M M Fanning, S E Read, et al.
Pageof 9